These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26376812)

  • 1. Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case-Control Study.
    Bertelsen B; Oranje B; Melchior L; Fagerlund B; Werge TM; Mikkelsen JD; Tümer Z; Glenthøj BY
    Neuromolecular Med; 2015 Dec; 17(4):423-30. PubMed ID: 26376812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.
    Liu X; Hong X; Chan RC; Kong F; Peng Z; Wan X; Wang C; Cheng L
    Psychiatry Res; 2013 Oct; 209(3):431-8. PubMed ID: 23598060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of Common Risk Variants and Polygenic Risk for Schizophrenia to Sensorimotor Gating.
    Roussos P; Giakoumaki SG; Zouraraki C; Fullard JF; Karagiorga VE; Tsapakis EM; Petraki Z; Siever LJ; Lencz T; Malhotra A; Spanaki C; Bitsios P
    Biol Psychiatry; 2016 Jun; 79(12):988-96. PubMed ID: 26212897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.
    Leonard S; Gault J; Hopkins J; Logel J; Vianzon R; Short M; Drebing C; Berger R; Venn D; Sirota P; Zerbe G; Olincy A; Ross RG; Adler LE; Freedman R
    Arch Gen Psychiatry; 2002 Dec; 59(12):1085-96. PubMed ID: 12470124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type.
    Martin LF; Leonard S; Hall MH; Tregellas JR; Freedman R; Olincy A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):611-4. PubMed ID: 17192894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Startle Modification and P50 Gating in Schizophrenia Patients and Controls: Russian Population.
    Storozheva ZI; Kirenskaya AV; Novototsky-Vlasov VY; Telesheva KY; Pletnikov M
    Span J Psychol; 2016 Mar; 19():E8. PubMed ID: 26936103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in P50 and prepulse inhibition of the startle reflex between male smokers and non-smokers with first episode schizophrenia without medical treatment.
    Song L; Chen X; Chen M; Tang Y; Wang J; Zhang M; Lou F; Liang J; Chen C
    Chin Med J (Engl); 2014; 127(9):1651-5. PubMed ID: 24791869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient prepulse inhibition of the startle reflex in schizophrenia using a cross-modal paradigm.
    Haß K; Bak N; Szycik GR; Glenthøj BY; Oranje B
    Biol Psychol; 2017 Sep; 128():112-116. PubMed ID: 28754277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHRNA4 was associated with prepulse inhibition of schizophrenia in Chinese: a pilot study.
    Shi J; Wang Z; Tan Y; Fan H; An H; Zuo L; Yang F; Tan S; Li J; Zhang X; Zhou D; Luo X
    Cogn Neuropsychiatry; 2016; 21(2):156-67. PubMed ID: 26982087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.
    Mann C; Croft RJ; Scholes KE; Dunne A; O'Neill BV; Leung S; Copolov D; Phan KL; Nathan PJ
    Neuropsychopharmacology; 2008 Jun; 33(7):1653-66. PubMed ID: 17895917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit.
    Houy E; Raux G; Thibaut F; Belmont A; Demily C; Allio G; Haouzir S; Fouldrin G; Petit M; Frebourg T; Campion D
    Mol Psychiatry; 2004 Mar; 9(3):320-2. PubMed ID: 14569275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large single ethnicity study of prepulse inhibition in schizophrenia: Separate analysis by sex focusing on effect of symptoms.
    Matsuo J; Ota M; Hori H; Hidese S; Teraishi T; Ishida I; Hiraishi M; Kunugi H
    J Psychiatr Res; 2016 Nov; 82():155-62. PubMed ID: 27505440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation regulates CHRNA7 transcription and can be modulated by valproate.
    Dyrvig M; Mikkelsen JD; Lichota J
    Neurosci Lett; 2019 Jun; 704():145-152. PubMed ID: 30974230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular variants at the promoter region of the human alpha 7 neuronal nicotinic acetylcholine receptor subunit gene but lack of association with schizophrenia.
    Li CH; Liao HM; Chen CH
    Neurosci Lett; 2004 Nov; 372(1-2):1-5. PubMed ID: 15531077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
    Stevens KE; Zheng L; Floyd KL; Stitzel JA
    Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit.
    Raux G; Bonnet-Brilhault F; Louchart S; Houy E; Gantier R; Levillain D; Allio G; Haouzir S; Petit M; Martinez M; Frebourg T; Thibaut F; Campion D
    Mol Psychiatry; 2002; 7(9):1006-11. PubMed ID: 12399955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical electroconvulsive stimulation alleviates breeding-induced prepulse inhibition deficit in rats.
    John N; Theilmann W; Frieling H; Krauss JK; Alam M; Schwabe K; Brandt C
    Exp Neurol; 2016 Jan; 275 Pt 1():99-103. PubMed ID: 26476178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History.
    Greenwood TA; Light GA; Swerdlow NR; Calkins ME; Green MF; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Olincy A; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Freedman R; Braff DL
    Am J Psychiatry; 2016 Apr; 173(4):385-91. PubMed ID: 26441157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.